How should I manage a patient whose urinalysis shows normal color and clarity, specific gravity 1.019, pH 5.5, no glucose, bilirubin, ketones, blood, protein, or nitrite, but microscopic 17 white blood cells per high‑power field and 11 red blood cells per high‑power field?

Management of Urinalysis Showing Pyuria and Hematuria

You should obtain a urine culture immediately and consider empiric antibiotic therapy if the patient has symptoms of urinary tract infection, while simultaneously evaluating for other causes of the combined pyuria and hematuria based on patient risk factors.

Interpretation of These Results

Your urinalysis shows two significant abnormalities:

• Pyuria: 17 WBC/HPF (normal 0-4) with positive leukocyte esterase (250 Leu/uL)
• Microscopic hematuria: 11 RBC/HPF (normal 0-2)
• Negative nitrites (important - suggests either non-nitrite-producing organism, inadequate bladder dwell time, or non-infectious cause)

Immediate Decision Algorithm

Step 1: Assess for UTI Symptoms

If symptomatic (fever, dysuria, flank pain, suprapubic pain, new/worsening incontinence):

• Obtain urine culture by catheterization or clean-catch method 1
• The combination of pyuria (≥10 WBC/HPF) plus positive leukocyte esterase warrants culture 2, 3
• Initiate empiric antibiotics based on local resistance patterns while awaiting culture 1

If asymptomatic:

• Do NOT treat empirically - asymptomatic bacteriuria with pyuria does not require antibiotics 2
• Proceed to Step 2 for hematuria evaluation

Step 2: Rule Out Contamination or Transient Causes

The presence of only 2 squamous epithelial cells/HPF suggests adequate specimen collection. However:

• Repeat urinalysis after excluding/treating:
  • Active menstruation
  • Recent vigorous exercise
  • Recent urologic instrumentation
  • Sexual activity within 48 hours 4

Step 3: Risk-Stratify for Genitourinary Malignancy

The hematuria (11 RBC/HPF) meets the threshold for microscopic hematuria requiring evaluation 5, 6, 7. Apply the 2025 AUA/SUFU Risk Stratification:

Low/Negligible Risk (requires ALL):

• 3-10 RBC/HPF
• Women <60 years OR men <40 years
• Never smoker or <10 pack-years
• No additional risk factors

Intermediate Risk (requires ONE or more):

• 11-25 RBC/HPF ← Your patient falls here
• Women ≥60 years OR men 40-59 years
• 10-30 pack-years smoking
• Any additional risk factors (occupational chemical exposure, history of gross hematuria, chronic UTI, pelvic irradiation, analgesic abuse)

High Risk (requires ONE or more):

• 25 RBC/HPF

• Men ≥60 years

• 30 pack-years smoking

• Multiple risk factors 6, 7

Management Based on Risk Category

If Low-Risk:

• Repeat urinalysis in 6 months
• If persistent hematuria, upgrade to intermediate-risk evaluation 7

If Intermediate-Risk (Most Likely for This Patient):

After UTI is excluded or treated:

1. Cystoscopy - to evaluate bladder and urethra 7
2. Renal and bladder ultrasound OR CT urography (CT preferred if age >40 or risk factors present) 4, 7
3. Measure blood pressure and serum creatinine to assess for medical renal disease 6, 7

If High-Risk:

• Full urologic evaluation with cystoscopy AND CT urography 7
• Consider urine cytology 4

Critical Pitfalls to Avoid

1. Do not dismiss hematuria after treating UTI - The hematuria may be unrelated to pyuria. Repeat urinalysis 6 weeks post-treatment; persistent hematuria requires full evaluation 1, 7

2. Do not rely on negative nitrites alone - Nitrites have poor sensitivity (only 38-50% for detecting significant pathology) 8. The combination of pyuria and hematuria demands culture if symptomatic 1

3. Do not skip malignancy workup in older patients - Risk of genitourinary malignancy increases significantly with age (up to 21% in older men with microscopic hematuria) 5

4. Acidic pH (5.5) may cause RBC lysis - Your result may underestimate true hematuria. If clinical suspicion is high, repeat urinalysis 9

5. Do not treat asymptomatic bacteriuria - If culture grows bacteria but patient lacks UTI symptoms, treatment does not improve outcomes and promotes resistance 2, 3

Specific Next Steps for Your Patient

1. Obtain detailed history: Age, sex, smoking history (pack-years), occupational exposures, prior gross hematuria, family history of urologic malignancy, current symptoms 6, 7

2. If symptomatic for UTI: Culture urine → start empiric antibiotics → repeat UA 6 weeks after treatment completion

3. If asymptomatic: Repeat UA to confirm persistent hematuria → risk-stratify → refer to urology for cystoscopy and imaging based on risk category 6, 7

4. Check serum creatinine and blood pressure - Proteinuria is negative, but combined hematuria/pyuria can indicate glomerular disease 6

The combination of significant pyuria (17 WBC/HPF) and hematuria (11 RBC/HPF) is uncommon and warrants thorough evaluation beyond simple UTI treatment, particularly if the patient has any malignancy risk factors 7, 8.